Associate Professor of Pathology, Brigham and Women's Hospital
Pathology
Dr. Shuji Ogino, MD
|
|
Give Review
Shuji Ogino works in the field of Pathology. He studied medicine at Graduate School of Medicine and Faculty of Medicine, The University of Tokyo. Shuji Ogino is a published doctor. He published 61 publications, including: 'Survival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer.' Shuji Ogino, MD accepts Medicare payments and is registered with Medicare.gov.
Publications
- Postdiagnostic intake of one-carbon nutrients and alcohol in relation to colorectal cancer survival.
- Survival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer.
- Marine Ï-3 Polyunsaturated Fatty Acids and Risk of Colorectal Cancer According to Microsatellite Instability.
- Early Life Body Fatness and Risk of Colorectal Cancer in U.S. Women and Men-Results from Two Large Cohort Studies.
- Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants.
- Red meat intake, NAT2, and risk of colorectal cancer: a pooled analysis of 11 studies.
- Aspirin and COX-2 inhibitor use in patients with stage III colon cancer.
- Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status.
- Derivation and validation of homocysteine score in u.s. Men and women.
- Lifecourse Epidemiology and Molecular Pathological Epidemiology.
- An integrative analysis reveals functional targets of GATA6 transcriptional regulation in gastric cancer.
- RNF43 is frequently mutated in colorectal and endometrial cancers.
- Alcohol, one-carbon nutrient intake, and risk of colorectal cancer according to tumor methylation level of IGF2 differentially methylated region.
- Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development.
- Prognostic Significance and Molecular Features of Signet-Ring Cell and Mucinous Components in Colorectal Carcinoma.
- Tumor LINE-1 Methylation Level and Microsatellite Instability in Relation to Colorectal Cancer Prognosis.
- SMO Expression in Colorectal Cancer: Associations with Clinical, Pathological, and Molecular Features.
- Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology.
- Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression.
- Progress and Opportunities in Molecular Pathological Epidemiology of Colorectal Premalignant Lesions.
- Urinary prostaglandin metabolites (PGE-M) are associated with risk of colorectal adenomas and chemopreventive response to anti-inflammatory drugs.
- Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of 15-Hydroxyprostaglandin Dehydrogenase (HPGD).
- A Prospective Study of Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15) and Risk of Colorectal Cancer.
- Evaluation of stromal HGF immunoreactivity as a biomarker for melanoma response to RAF inhibitors.
- Aspirin Use, 8q24 Single Nucleotide Polymorphism rs6983267, and Colorectal Cancer According to CTNNB1 Alterations.
- Predictive and Prognostic Analysis of PIK3CA Mutation in Stage III Colon Cancer Intergroup Trial.
- Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.
- Towards the introduction of the Immunoscore in the classification of malignant tumors.
- Plasma adiponectin and soluble leptin receptor and risk of colorectal cancer: a prospective study.
- Long-term colorectal-cancer incidence and mortality after lower endoscopy.
- Microsatellite Instability and BRAF Mutation Testing in Colorectal Cancer Prognostication.
- Hyperglycemia, Insulin Resistance, Impaired Pancreatic β-Cell Function, and Risk of Pancreatic Cancer.
- Anatomic subsite of primary colorectal cancer and subsequent risk and distribution of second cancers.
- Aspirin use and risk of colorectal cancer according to BRAF mutation status.
- Physical Activity, Tumor PTGS2 Expression, and Survival in Patients with Colorectal Cancer.
- Inflammatory plasma markers and pancreatic cancer risk: a prospective study of five u.s. Cohorts.
- A prospective study of plasma inflammatory markers and risk of colorectal cancer in men.
- Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity.
- Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease.
- A Prospective Study of Plasma Adiponectin and Pancreatic Cancer Risk in Five US Cohorts.
- Prospective Study of Family History and Colorectal Cancer Risk by Tumor LINE-1 Methylation Level.
- Restriction of intestinal stem cell expansion and the regenerative response by YAP.
- Phenotypic and tumor molecular characterization of colorectal cancer in relation to a susceptibility SMAD7 variant associated with survival.
- Expression Profiling of Archival Tumors for Long-term Health Studies.
- Gastrointestinal Adenocarcinomas of the Esophagus, Stomach, and Colon Exhibit Distinct Patterns of Genome Instability and Oncogenesis.
- Specific Mutations in KRAS Codons 12 and 13, and Patient Prognosis in 1075 BRAF Wild-Type Colorectal Cancers.
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion.
- No evidence for interference of h&e staining in DNA testing: usefulness of DNA extraction from h&e-stained archival tissue sections.
- Postmenopausal Hormone Therapy Is Associated with a Reduced Risk of Colorectal Cancer Lacking CDKN1A Expression.
- A Prospective Study of Bisphosphonate Use and Risk of Colorectal Cancer.
- Colorectal cancer: a tale of two sides or a continuum?
- Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum.
- Differential WNT Activity in Colorectal Cancer Confers Limited Tumorigenic Potential and Is Regulated by MAPK Signaling.
- Colorectal cancer expression of peroxisome proliferator-activated receptor gamma (PPARG, PPARgamma) is associated with good prognosis.
- PIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancer.
- CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer.
- Cohort study of fatty acid synthase expression and patient survival in colon cancer.
- Post diagnosis diet quality and colorectal cancer survival in women.
- Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review.
- Sugar-Sweetened Beverage Intake and Cancer Recurrence and Survival in CALGB 89803 (Alliance).
Schools
Tokyo Imperial University Faculty Of Med
Allegheny Gen Hospital
University Pennsylvania Med Center
Doctors Specialties
- Molecular Genetic Pathology
- Pathology
Accepted Insurances
Education
-
University of Pennsylvania Health System -
Case Western Reserve University - University Hospitals -
Allegheny General Hospital - Western Pennsylvania Hospital -
Graduate School of Medicine and Faculty of Medicine, The University of Tokyo
Hospital
-
Brigham and Women's Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1285683367 |
| Last Name Of The Provider | OGINO |
| First Name Of The Provider | SHUJI |
| View All |
Similar Doctors
|
|
Dr. Anthony J. Iafrate, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer L. Hunt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zoltan Nagymanyoki, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William J. Lane, MD |
|
|
Dr. Melanie Johncilla, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alanna J. Church, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew J. Schell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marcin B. Imielinski, MD |
|
|
Dr. Felicia D. Allard, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janina A. Longtine, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tracie Pham, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Tee Lang, MB CHB |
|
|
Dr. Manana Kvezereli, MD
This Doctor is OpenDoctor Recommended.
|